Brussels, My Love?
State Of The Union
Good Morning Europe
The Global Conversation
Top News Stories Today
Hacker Hunter Next Level
Soul Of The South
Women Beyond Borders
Farm To Fork
Green In The City
Low Impact Living
Cry Like A Boy
Meet The Locals
Melting Pot Culture
The Star Ingredient
Depth Of Field
Here We Grow: Spain
The New Uzbekistan
A Greener Future
All You Want Is Greece
Digital Garden City Nation
Galaxy Brain Investor
Invest In Brazil
Under The Hood
Ukraine Russia war
More about this topic
Moderna sues Pfizer-BioNTech for copying tech behind COVID vaccines
UKRAINE RUSSIA WAR
More about this topic
Von der Leyen text messages to Pfizer CEO 'should be released'
Critics say the European Commission has become less transparent, less accountable and "unhinged" from European democracy.
EMA approves Pfizer's anti-COVID pill for use in the EU
The antiviral drug Paxlovid reduced hospital admissions and deaths from COVID in at-risk people by up to 90 per cent, Pfizer said.
Pfizer/BioNTech to start clinical trials on new Omicron COVID vaccine
A new formulation of the COVID-19 jab based on the highly infectious Omicron variant is now in clinical trials, the drugmakers said on Tuesday
'Nocebo effect' cause of most COVID vaccine side effects, study says
Researchers say many of the common COVID vaccine side effects could actually be down to the "nocebo effect," the negative placebo effect.
Get ready for yearly COVID-flu combo vaccines, say Moderna and Pfizer
Vaccine maker Moderna predicted that its seasonal COVID and flu boosters would be available in some countries within the next two years.
Panama vaccinates children against Covid-19 amid surge in cases
Panama starts vaccinating children between the ages of five and eleven against Covid-19, in an effort to resume in-person learning at schools amid a new surge in cases.
This will impact your life
Brussels mulls joint EU purchase of new antiviral COVID pills
The European Commission is in talks with pharmaceutical companies to buy the antiviral pills, which can be taken orally at home.
US FDA expands Pfizer boosters for more teens amid Omicron surge
Boosters already are recommended for everyone 16 and older, and federal regulators on Monday decided they're also warranted for 12- to 15-year-olds once enough time has passed since their last dose.
Israel offers fourth vaccine dose to citizens aged 60 and over
Israel has been a pioneer in vaccinating its citizens against the coronavirus and began offering a third dose to citizens as early as last summer.
COVID vaccines are not enough for Omicron variant, warns BioNTech CEO
"We must be aware that even triple-vaccinated are likely to transmit the disease’” Ughur Sahin said, the CEO of the German company behind the mRNA vaccine produced with Pfizer.
Pfizer study finds its COVID pill reduces hospitalisation by nearly 90
The drugs manufacturer’s study on its COVID-19 oral antiviral found it reduced risk of hospitalisation or death by 89% within three days of symptom onset.
Pfizer says COVID booster offers protection against Omicron
"What we should really be reading into this is that any vaccine that boosts immunity will do the job," clinical expert Bharat Pankhania told Euronews.
Here’s what COVID vaccine makers are doing about the Omicron variant
COVID vaccine manufacturers are racing to develop new doses to combat the rising number of cases connected to the Omicron variant.
Pfizer to allow developing countries to make and sell its COVID pill
The new deal will mean that more than half the world's population will be able to access the treatment cheaply.
Pfizer’s says its COVID pill is highly effective in high risk cases
The pharmaceutical company says it intends to ask for authorisation for the pill from international regulators.
Pfizer's COVID vaccine can now be used on children aged 5-11 in the US
President Joe Biden hailed the move as a "turning point" in the fight against the pandemic.
Pfizer’s COVID vaccine ‘91% effective’ in children aged 5-11
Young children were found to have strong protection from COVID-19 with Pfizer's COVID vaccine according to new data.
Pfizer says its COVID vaccine works in children aged 5-11
The laboratory said it will be seeking FDA approval in the US to administer its vaccine to children under 12.
Blood clot risk from vaccines ‘much lower’ than those from COVID-19
A new study by the BMJ found there was an increased risk of rare blood clots associated with AstraZeneca and Pfizer’s vaccine, but that risk was much higher in patients who tested positive for coronavirus.
COVID-19 booster shots already underway in several countries
Some countries are starting to offer a third dose of the COVID-19 vaccine for the most vulnerable, in an attempt to combat the spread of the Delta variant.